Frankfurt - Delayed Quote EUR

Apellis Pharmaceuticals, Inc. (1JK.F)

Compare
28.58
+0.94
+(3.40%)
At close: January 31 at 8:16:34 AM GMT+1

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
CHOPAS JAMES GEORGE Officer Sale Jan 22, 2025 48,138
DELONG MARK JEFFREY Officer Sale Jan 29, 2025 84,308
DESCHATELETS PASCAL Officer Sale Jan 29, 2025 1,147,720
EISELE JEFFREY Officer Sale Jan 29, 2025 55,312
FRANCOIS CEDRIC G Chief Executive Officer Sale Jan 29, 2025 1,955,120
LEWIS KAREN Officer Sale Jan 29, 2025 70,251
NICHOLSON NUR Chief Technology Officer Sale Jan 29, 2025 83,664
SULLIVAN TIMOTHY EUGENE Chief Financial Officer Sale Jan 29, 2025 199,061
TOWNSEND ADAM J Officer Sale Jan 29, 2025 84,050
WATSON DAVID O General Counsel Sale Jan 29, 2025 224,435

Related Tickers